Perspectives
Commentary
Alarming global rise in pediatric hepatitis: Expert Q&A
For pediatricians, an awareness of the “outbreak” may allow the clinician to extend the typical workup of a child presenting with an undefined,...
Perspectives
An aspirin a day ... for CRC?
What about that wonder drug – the ubiquitous aspirin? Should gastroenterologists be the ones to recommend or even prescribe aspirin?
Perspectives
Is proactive TDM the way to go?
Reactive drug monitoring has been adapted into a more proactive method by some with the hope that this may prevent loss of efficacy and adverse...
Perspectives
Are GI hospitalists the future of inpatient care?
Is this the new ideal, allowing for more efficient care? Or are traditional or alternative models more appropriate?
Perspectives
Is telemedicine here to stay?
Is telemedicine the new office visit or is just good enough for when we really need it?
Perspectives
Should the starting age for CRC screening be lowered to 45?
Two renowned experts debate the pros and cons of this paradigm change.
Perspectives
Does MELD need an update?
MELD has proven adaptable, but with demographics changes over the last 20 years, it may need evolve to meet the present-day transplant needs.
Perspectives
When should antibiotics be used in acute uncomplicated diverticulitis?
What does “selectively” versus “routinely” even mean in diverticulitis?
Perspectives
Should all patients be tested for SARS-CoV-2 before endoscopy?
How should endoscopy centers balance reassuring patients and providers without also creating undue barriers to care?
Perspectives
Should your practice be acquired by private equity?
Dr. John Allen and Dr. Marc Sonenshine explain private equity’s evolution in the GI field, dispel misconceptions, and dissect the central question...